New Avenues in Lung Cancer Treatment: The Role of Exosome-based Inhalable Immunotherapy
A Breakthrough Study from Columbia University Introduces Inhalable Exosome Technology as a Promising Alternative for Lung Cancer Therapy
Topline:
A recent study from Columbia University, published in Nature Nanotechnology, highlights the potential of exosome-based inhalable immunotherapy to target lung cancer cells directly, offering a non-invasive and localized treatment method that minimizes side effects compared to traditional systemic chemotherapy.
